|
Volumn 2, Issue 4, 2000, Pages 277-282
|
Future possibilities in the prevention of breast cancer. Role of genetic variation in breast cancer prevention
|
Author keywords
Breast cancer; Epidemiology; Polymorphism; Prevention; Risk factors
|
Indexed keywords
HORMONE;
ORAL CONTRACEPTIVE AGENT;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
ADULT;
AGED;
ALLELE;
BREAST CANCER;
CANCER GENETICS;
CANCER MODEL;
CANCER PREVENTION;
CANCER SCREENING;
CANCER SUSCEPTIBILITY;
CATARACT;
ENDOMETRIUM CANCER;
FEMALE;
GENETIC MARKER;
GENETIC VARIABILITY;
HIGH RISK POPULATION;
HUMAN;
MAJOR CLINICAL STUDY;
MULTIGENE FAMILY;
REPRODUCTION;
REVIEW;
RISK FACTOR;
STROKE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTICARCINOGENIC AGENTS;
AROMATASE;
BREAST NEOPLASMS;
CASE-CONTROL STUDIES;
ESTRADIOL DEHYDROGENASES;
ESTROGEN RECEPTOR ALPHA;
ESTROGENS;
ETHNIC GROUPS;
FEMALE;
FORECASTING;
GENETIC PREDISPOSITION TO DISEASE;
GENETIC SCREENING;
HUMANS;
MIDDLE AGED;
MODELS, GENETIC;
OVARY;
POLYMORPHISM, GENETIC;
RALOXIFENE;
RECEPTORS, ESTROGEN;
REPRODUCTIVE HISTORY;
RISK FACTORS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
STEROID 17-ALPHA-HYDROXYLASE;
TAMOXIFEN;
|
EID: 0034467033
PISSN: 14655411
EISSN: None
Source Type: Journal
DOI: 10.1186/bcr69 Document Type: Review |
Times cited : (23)
|
References (20)
|